Close
Close
Treatment Database
nanatinostat and valganciclovir
Trade Name not avaiable
Orphan Indication Angioimmunoblastic T-cell lymphoma
USA Market Approval
USA Designation Date 15-03-2019
Sponsor Viracta Therapeutics, Inc.
2533 South Coast Highway, Suite 210
Carlsbad, California, 92007
More about T-cell lymphoma
Free Newsletter
Treatment News
Related Videos
by Abidemi Uruejoma
7,246 views